Follow the Immutep Limited stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Immutep Limited has logged 10 public disclosures. Market capitalisation: €73.7m. The latest transaction was reported on 16 June 2026 (Initial Substantial Holding). Among the most active insiders: 129 188 450 REGAL PARTNERS LIMITED. The full history is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Immutep Limited is a biopharmaceutical company focused on developing immunotherapy treatments for cancer and other diseases. It is listed on the XASX market.